Literature DB >> 6982167

The enhancement of 5-fluorouracil anti-metabolic activity by leucovorin, menadione and alpha-tocopherol.

S Waxman, H Bruckner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6982167     DOI: 10.1016/0277-5379(82)90215-2

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


× No keyword cloud information.
  8 in total

1.  Weekly fluorouracil and high-dose leucovorin: efficacy and treatment of cutaneous toxicity.

Authors:  J E Mortimer; I Anderson
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Folinic acid modulation of fluorouracil: tissue kinetics of bolus administration.

Authors:  C P Spears; B G Gustavsson; R Frösing
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

Review 3.  Oral Tegafur-Uracil Combination plus Leucovorin versus Other Fluoropyrimidine Agents in Colorectal Cancer: A Systematic Review and Meta-Analysis.

Authors:  Satya Pal Kataria; Mukesh Nagar; Shikha Verma; Vinay Purohit
Journal:  South Asian J Cancer       Date:  2022-02-02

4.  5-Fluorouracil and low-dose leucovorin in metastatic colorectal cancer: a pilot study.

Authors:  G Fried; M Tsalik; M Stein; J Dale; N Haim
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

5.  Folinic acid effect on 5-fluorouracil kinetics in vivo.

Authors:  R Herrmann; J Reuter; R Port; H Osswald
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

Review 6.  New targets for pyrimidine antimetabolites in the treatment of solid tumours. 1: Thymidylate synthase.

Authors:  C L van der Wilt; G J Peters
Journal:  Pharm World Sci       Date:  1994-04-15

7.  The Electroporation as a Tool for Studying the Role of Plasma Membrane in the Mechanism of Cytotoxicity of Bisphosphonates and Menadione.

Authors:  Mantas Šilkūnas; Rita Saulė; Danutė Batiuškaitė; Gintautas Saulis
Journal:  J Membr Biol       Date:  2016-04-04       Impact factor: 1.843

Review 8.  Vitamins and Melanoma.

Authors:  Irene Russo; Francesca Caroppo; Mauro Alaibac
Journal:  Cancers (Basel)       Date:  2015-07-24       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.